Advent International, a private equity firm focused on buyouts of companies, announced on September 11 that it sold Zentiva to GTCR. Zentiva is a leading European generics pharmaceutical company with a focus on developing, producing and delivering affordable medicines to more than 100 million people in more than 30 countries across […]
The post Advent International Sells Zentiva to GTCR appeared first on LevinPro Healthcare M&A – The latest healthcare M&A news.
